1
|
Uozaki M, Yamasaki H, Katsuyama Y, Higuchi
M, Higuti T and Koyama AH: Antiviral effect of octyl gallate
against DNA and RNA viruses. Antiviral Res. 73:85–91. 2007.
View Article : Google Scholar
|
2
|
Yamasaki H, Tsujimoto K, Koyama AH, Ejima
D and Arakawa T: Arginine facilitates inactivation of enveloped
viruses. J Pharm Sci. 97:3067–3073. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Arakawa T, Yamasaki H, Ikeda K, Ejima D,
Naito T and Koyama AH: Antiviral and virucidal activities of
natural products. Curr Med Chem. 16:2485–2497. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Uozaki M, Ikeda K, Tujimoto K, et al:
Antiviral effects of dehydroascorbic acid. Exp Ther Med. 1:983–986.
2010.PubMed/NCBI
|
5
|
Ikeda K, Yamasaki H, Suzuki Y, Koyama AH
and Arakawa T: Novel strategy with acidic arginine solution for the
treatment of influenza A virus infection. Exp Ther Med. 1:251–256.
2010.PubMed/NCBI
|
6
|
Ikeda K, Yamasaki H, Minami S, et al:
Arginine inactivates human herpesvirus 2 and inhibits genital
herpesvirus infection. Int J Mol Med. 30:1307–1312. 2012.PubMed/NCBI
|
7
|
American Medical Association. General
infection and infestations; influenza. American Medical Association
Family Medical Guide. Clayman CB: 3rd edition. Random House, Inc;
New York, NY: pp. 597–598. 1994
|
8
|
Brankston G, Gitterman L, Hirji Z, Lemieux
C and Gardam M: Transmission of influenza a in human beings. Lancet
Infect Dis. 7:257–265. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wright PF, Newman G and Kawaoka Y:
Orthomyxoviruses. Fields Virology. Knipe DM, Howley PM, Griffin DE,
et al: 5th edition. Lippincott Williams and Wilkins; Philadelphia,
PA: pp. 1691–1740. 2007
|
10
|
Laevens H, Koenen F, Deluyker H and de
Kruif A: Experimental infection of slaughter pigs with classical
swine fever virus: transmission of the virus, course of the disease
and antibody response. Vet Rec. 145:243–248. 1999. View Article : Google Scholar : PubMed/NCBI
|
11
|
Lai MY, Cheng PK and Lim WW: Survival of
severe acute respiratory syndrome coronavirus. Clin Infect Dis.
41:e67–e71. 2005. View
Article : Google Scholar : PubMed/NCBI
|
12
|
Sakaguchi H, Wada K, Kajioka J, et al:
Maintenance of influenza virus infectivity on the surfaces of
personal protective equipment and clothing used in healthcare
settings. Environ Health Prev Med. 15:344–349. 2010. View Article : Google Scholar :
|
13
|
Kurokawa M, Koyama AH, Yasuoka S and
Adachi A: Influenza virus overcomes apoptosis by rapid
multiplication. Int J Mol Med. 3:527–530. 1999.PubMed/NCBI
|
14
|
Nishide M, Tsujimoto K, Uozaki M, Ikeda K,
Yamasaki H, Koyama AH and Arakawa T: Effect of electrolytes on
virus inactivation by acidic solutions. Int J Mol Med. 27:803–809.
2011.PubMed/NCBI
|